Skip to contentA
Aeternum Health, Inc.
A
AETNAeternum Health, Inc. Q2 2026 · 10-Q
Revenue—
Net Income$1.72M$1.72MN/M vs Q2 2025 EPS Diluted$0.03$0.03— vs Q2 2025 Operating Income-$270,879N/M Operating Cash Flowderived-$1,522,347N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aeternum Health, Inc. · CIK 764630 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 19, 2026 · 50 d after period end